Cellectar Biosciences, Inc. (CLRB) NASDAQ
2.79
-0.095(-3.30%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.79
-0.095(-3.30%)
Currency In USD
| Market Cap | 7.69M |
| Enterprise Value | -5.09M |
| P/E Ratio | -0.54 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.19 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.17 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.45 |
| Return On Equity | -2.49 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -213,597 |
| EBITDA | -22.77M |
| Net Income | -21.79M |
| Diluted EPS | -8.35 |
| Total Cash | 13.2M |
| Total Cash/Share | 3.11 |
| Total Debt | 409,586 |
| Total Debt/Equity | 0.04 |
| Current Ratio | 2.96 |
| Book Value Per Share | 2.34 |
| 52-Week Change | -70.34 |
| 52-Week High | 20.7 |
| 52-Week Low | 2.43 |
| Moving Average 50 Days | 3 |
| Moving Average 200 Days | 3.86 |
| Average Volume | 36,895 |
| Shares Outstanding | 3.19M |
| % Held by Institutions | 7.49 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
| Last Split Date | June 23, 2025 |